2410 lines
343 KiB
CSV
2410 lines
343 KiB
CSV
"Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies.",,,,,,,,,,,,,,,,,,,
|
|
Subject,Subject Data Revision,Screen No.,Age,Age Unit,Gender,Visit,Visit Data Revision,Collected Time,Accession,Test Group,Test,Administrative Question,Value,Result Data Revision,Flags,Cancellation Reason,Comments,Range,Units
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.2,,,,,0 - 5,mg/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Alkaline Phosphatase,,59,,,,,35 - 104,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,LDH,,176,,,,,53 - 234,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,74,,,,,31 - 101,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Uric Acid,,289,,,,,149 - 446,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Phosphorus,,1.12,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Creatine Kinase,,263,,H,,,26 - 192,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,139,,,,Result verified by repeat analysis,116 - 164,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,Result verified by repeat analysis,0.34 - 0.48,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,Result verified by repeat analysis,79 - 98,fL
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.14,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.07,,,,,1.96 - 7.23,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.57,,,,,0.91 - 4.28,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.0,,,,,40.5 - 75,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.0,,,,,15.4 - 48.5,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,309,,,,Result verified by repeat analysis,140 - 400,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.37,,,,,1.9 - 23,uIU/mL
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Direct HDL-C 4th Generation,,1.79,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Triglycerides (GPO),,1.51,,,,,0.59 - 2.96,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,Cholesterol (High Performance),,5.75,,,,,4.42 - 7.53,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,LIPID PANEL,LDL Chol Friedewald 4th,,3.27,,,,,0 - 3.34,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,TSH,TSH 3rd IS-QT,,4.824,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"May 13, 2026 8:15 AM",6228234298,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,C-REACTIVE PROTEIN,C Reactive Protein HS,,7.3,,H,,,0 - 5,mg/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.9,,,,,0 - 6.2,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,40 - 129,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,ALT (SGPT),,163,,H RX,,,5 - 48,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,AST (SGOT),,127,,H RX,,,8 - 40,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,GGT,,350,,HT,,Result verified by repeat analysis,10 - 50,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,LDH,,224,,,,,53 - 234,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,106,,,,,40 - 119,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Uric Acid,,512,,H,,,149 - 494,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Calcium (EDTA),,2.39,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Creatine Kinase,,348,,H,,,39 - 308,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,134,,,,,125 - 170,g/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.37 - 0.51,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4 - 5.8,TI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,100,,,,,80 - 100,fL
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.89,,,,,3.8 - 10.7,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.35,,,,,1.96 - 7.23,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.13,,,,,0.8 - 3,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.03,,,,,0 - 0.57,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,60.5,,,,,40.5 - 75,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.0,,,,,15.4 - 48.5,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.7,,,,,2.6 - 10.1,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,137,R,L,,,140 - 400,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.3,,,,,<6.5 %,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,30.61,,H,,,1.9 - 23,uIU/mL
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Direct HDL-C 4th Generation,,1.03,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Triglycerides (GPO),,2.89,,,,,0.65 - 3.61,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,Cholesterol (High Performance),,4.82,,,,,4.4 - 7.53,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,LIPID PANEL,LDL Chol Friedewald 4th,,2.47,,,,,0 - 3.34,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,TSH,TSH 3rd IS-QT,,1.982,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"May 4, 2026 8:44 AM",6228234297,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Alkaline Phosphatase,,92,,,,,40 - 129,U/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,5 - 48,U/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Urea Nitrogen,,4.6,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 110,umol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Glucose Fasting,,5.1,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Uric Acid,,249,,,,,125 - 488,umol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Albumin-BCG,,50,R,H,,,33 - 49,g/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Creatine Kinase,,224,,,,,39 - 308,U/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Bicarbonate,,27.9,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,CHEMISTRY PANEL,Serum Chloride,,98,,,,,94 - 112,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,127 - 181,g/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 96,fL
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.75,,,,,3.8 - 10.7,GI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.09,,,,,1.96 - 7.23,GI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.22,,,,,0.91 - 4.28,GI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.35,,,,,0.12 - 0.92,GI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.0,,,,,40.5 - 75,%
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,25.8,,,,,15.4 - 48.5,%
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,%
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.4,,,,,0 - 6.8,%
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,%
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,216,,,,,140 - 400,GI/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.44,,,,,1.9 - 23,uIU/mL
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Direct HDL-C 4th Generation,,1.34,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Triglycerides (GPO),,0.59,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,Cholesterol (High Performance),,3.92,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,LIPID PANEL,LDL Chol Friedewald 4th,,2.31,,,,,0 - 3.34,mmol/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,%
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,TSH,TSH 3rd IS-QT,,1.256,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Specific Gravity,,1.012,,,,,1 - 1.04,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,End of Phase/Treatment,,"Apr 21, 2026 10:37 AM",6228234300,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.3,,,,,0 - 5,mg/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.8,,,,,0 - 6.2,umol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Alkaline Phosphatase,,104,,,,,40 - 129,U/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,ALT (SGPT),,17,,,,,5 - 48,U/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,LDH,,,,,Test cancelled: Hemolysis-test not performed,,,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Urea Nitrogen,,6.2,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,125 - 488,umol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Calcium (EDTA),,2.45,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Albumin-BCG,,52,,H,,,33 - 49,g/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Creatine Kinase,,196,,,,,39 - 308,U/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.59,,,,,1.42 - 2.08,mL/sec
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 110,umol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,64.0,,,,,kg,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,FSH,Follicle Stimulating Hormone,,6.14,,RX,,,1.3 - 19.3,IU/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,127 - 181,g/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.24,,,,,3.8 - 10.7,GI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.97,,,,,1.96 - 7.23,GI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.12,,,,,0 - 0.57,GI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,63.6,,,,,40.5 - 75,%
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.6,,,,,15.4 - 48.5,%
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,%
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,%
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,%
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,223,,,,,140 - 400,GI/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.3,,,,,<6.5 %,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.85,,,,,1.9 - 23,uIU/mL
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Direct HDL-C 4th Generation,,1.40,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Triglycerides (GPO),,0.81,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,Cholesterol (High Performance),,4.33,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,LIPID PANEL,LDL Chol Friedewald 4th,,2.56,,,,,0 - 3.34,mmol/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,%
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,TSH,TSH 3rd IS-QT,,1.789,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Specific Gravity,,1.028,,,,,1 - 1.04,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Retest,,"Apr 10, 2026 8:16 AM",6227542182,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.1,,,,,0 - 5,mg/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Alkaline Phosphatase,,58,,,,,40 - 129,U/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,ALT (SGPT),,86,,H RX,,,5 - 48,U/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,AST (SGOT),,74,,H RX,,,8 - 40,U/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,GGT,,83,,H,,,10 - 50,U/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,LDH,,187,,,,,53 - 234,U/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Urea Nitrogen,,5.4,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,107,,,,,40 - 119,umol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Glucose Fasting,,8.0,,H,,,3.9 - 5.6,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Uric Acid,,500,,H,,,149 - 494,umol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Total Protein,,77,,,,,60 - 80,g/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Creatine Kinase,,238,,,,,39 - 308,U/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Sodium,,137,,,,,135 - 145,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Potassium,,3.8,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,CHEMISTRY PANEL,Serum Chloride,,99,,,,,94 - 112,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,137,,,,,125 - 170,g/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.37 - 0.51,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4 - 5.8,TI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.57,,,,,3.8 - 10.7,GI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.18,,,,,1.96 - 7.23,GI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.84,,,,,0.8 - 3,GI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.44,,,,,0.12 - 0.92,GI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,%
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.0,,,,,15.4 - 48.5,%
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.9,,,,,2.6 - 10.1,%
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.0,,,,,0 - 6.8,%
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,%
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,169,,,,,140 - 400,GI/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.13,,H,,,1.9 - 23,uIU/mL
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Direct HDL-C 4th Generation,,0.70,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Triglycerides (GPO),,2.48,,,,,0.65 - 3.61,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,Cholesterol (High Performance),,4.55,,,,,4.4 - 7.53,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,%
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1.01 - 1.03,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 2 OL Induction Day 29,,"Apr 7, 2026 9:21 AM",6228114460,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.7,,,,,0 - 5,mg/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Total Bilirubin,,15,,,,,3 - 21,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.6,,,,,0 - 6.2,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Alkaline Phosphatase,,101,,,,,35 - 104,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,ALT (SGPT),,19,,,,,4 - 43,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,LDH,,175,,,,,53 - 234,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Urea Nitrogen,,3.9,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,54,,,,,31 - 101,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,125 - 428,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Total Protein,,80,,,,,61 - 84,g/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Creatine Kinase,,52,,,,,26 - 192,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,CRYSTALS,Ur Uric Acid Crystals,,Present,,,,,Ref Rng:Not present,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,FREE T4,Free Thyroxine-QT,,18,,H,,,8 - 14,pmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,116 - 164,g/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.85,,,,,3.8 - 10.7,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.16,,,,,1.96 - 7.23,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.28,,,,,0.91 - 4.28,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.31,,,,,0.12 - 0.92,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.0,,,,,40.5 - 75,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.9,,,,,15.4 - 48.5,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,312,,,,,140 - 400,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.7,,,,,<6.5 %,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.75,,,,,1.9 - 23,uIU/mL
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Direct HDL-C 4th Generation,,1.07,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Triglycerides (GPO),,0.77,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,Cholesterol (High Performance),,3.77,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,LIPID PANEL,LDL Chol Friedewald 4th,,2.35,,,,,0 - 3.34,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,RETICULOCYTES,Reticulocyte Count %,,1.5,,,,,0.6 - 2.5,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,TSH,TSH 3rd IS-QT,,0.119,,L SF,,,0.45 - 5.33,mIU/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,,"Mar 31, 2026 10:10 AM",6228232037,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Total Bilirubin,,5,,,,,3 - 21,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Alkaline Phosphatase,,53,,,,,35 - 104,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,GGT,,12,,,,,4 - 49,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,LDH,,134,,,,,53 - 234,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Urea Nitrogen,,5.0,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Uric Acid,,216,,,,,125 - 428,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Phosphorus,,0.83,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Total Protein,,65,,,,,61 - 84,g/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Creatine Kinase,,83,,,,,26 - 192,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Bicarbonate,,23.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,CHEMISTRY PANEL,Serum Chloride,,106,,,,,94 - 112,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,,,,116 - 164,g/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.36,,,,,0.34 - 0.48,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,L,,,4.1 - 5.6,TI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.63,,,,,3.8 - 10.7,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.66,,,,,1.96 - 7.23,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.20,,,,,0.12 - 0.92,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,35.3,,,,,15.4 - 48.5,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.3,,,,,2.6 - 10.1,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.4,,,,,0 - 6.8,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,273,,,,,140 - 400,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.32,,,,,1.9 - 23,uIU/mL
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Direct HDL-C 4th Generation,,1.68,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,Cholesterol (High Performance),,4.75,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,TSH,TSH 3rd IS-QT,,1.607,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Specific Gravity,,1.027,,,,,1 - 1.04,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Mar 30, 2026 9:31 AM",6227542172,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Alkaline Phosphatase,,64,,,,,35 - 104,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,GGT,,30,,,,,4 - 49,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,LDH,,164,,,,,53 - 234,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Uric Acid,,315,,,,,149 - 446,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Creatine Kinase,,151,,,,,26 - 192,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Bicarbonate,,24.8,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,135,,,,,116 - 164,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.44,,,,,3.8 - 10.7,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.89,,,,,1.96 - 7.23,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.02,,,,,0.91 - 4.28,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.3,,,,,40.5 - 75,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,40.6,,,,,15.4 - 48.5,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,307,,,,,140 - 400,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.4,,,,,<6.5 %,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.60,,,,,1.9 - 23,uIU/mL
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Direct HDL-C 4th Generation,,1.98,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.59 - 2.96,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,Cholesterol (High Performance),,5.66,,,,,4.42 - 7.53,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,TSH,TSH 3rd IS-QT,,3.912,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Specific Gravity,,1.025,,,,,1 - 1.04,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Mar 16, 2026 9:16 AM",6227542171,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 5,/HPF
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.2,,,,,0 - 6.2,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Alkaline Phosphatase,,91,,,,,40 - 129,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,ALT (SGPT),,29,,,,,5 - 48,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,AST (SGOT),,39,,,,,8 - 40,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,LDH,,206,,,,,53 - 234,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Urea Nitrogen,,5.5,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Glucose Fasting,,5.6,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Uric Acid,,223,,,,,125 - 488,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Calcium (EDTA),,2.58,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Albumin-BCG,,51,R,H,,,33 - 49,g/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Creatine Kinase,,1857,R,H SF,,Diluted for quantitation,39 - 308,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Bicarbonate,,23.1,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.45,,,,,0.39 - 0.54,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,87,,,,,79 - 96,fL
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.41,,,,,3.8 - 10.7,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.57,,,,,1.96 - 7.23,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.23,,,,,0.91 - 4.28,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.48,,,,,0.12 - 0.92,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.08,,,,,0 - 0.57,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,71.3,,,,,40.5 - 75,%
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,%
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.5,,,,,2.6 - 10.1,%
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,%
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,%
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,242,,,,,140 - 400,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.71,,,,,1.9 - 23,uIU/mL
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Triglycerides (GPO),,1.12,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,Cholesterol (High Performance),,3.95,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,LIPID PANEL,LDL Chol Friedewald 4th,,2.21,,,,,0 - 3.34,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,%
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Specific Gravity,,1.036,R,H,,,1 - 1.04,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Protein,,Trace,R,H,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 DB Baseline,,"Mar 10, 2026 10:21 AM",6227844725,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.7,,,,,0 - 5,mg/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.1,,,,,0 - 6.2,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Alkaline Phosphatase,,53,,,,,40 - 129,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,ALT (SGPT),,79,,H RX,,,5 - 48,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,AST (SGOT),,46,,H,,,8 - 40,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,GGT,,68,,H,,,10 - 50,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,95,,,,,40 - 119,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Glucose Fasting,,7.0,,H,,,3.9 - 5.6,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Uric Acid,,393,,,,,149 - 494,umol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Calcium (EDTA),,2.28,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Phosphorus,,0.81,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Total Protein,,72,,,,,60 - 80,g/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Creatine Kinase,,212,,,,,39 - 308,U/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Bicarbonate,,22.5,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,125 - 170,g/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.37 - 0.51,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4 - 5.8,TI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,98,,,,,80 - 100,fL
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.42,,,,,3.8 - 10.7,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.42,,,,,1.96 - 7.23,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.61,,,,,0.8 - 3,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.28,,,,,0.12 - 0.92,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.8,,,,,40.5 - 75,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.4,,,,,15.4 - 48.5,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.4,,,,,2.6 - 10.1,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.3,,,,,0 - 6.8,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,149,,,,,140 - 400,GI/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.2,,,,,<6.5 %,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,33.25,R,H,,,1.9 - 23,uIU/mL
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Direct HDL-C 4th Generation,,0.79,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Triglycerides (GPO),,2.48,,,,,0.65 - 3.61,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,Cholesterol (High Performance),,4.67,,,,,4.4 - 7.53,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,LIPID PANEL,LDL Chol Friedewald 4th,,2.74,,,,,0 - 3.34,mmol/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,%
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,TSH,TSH 3rd IS-QT,,1.053,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1.01 - 1.03,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,End of Phase/Treatment,,"Mar 10, 2026 9:30 AM",6227542170,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,40 - 129,U/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,ALT (SGPT),,22,,,,,5 - 48,U/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,AST (SGOT),,17,,,,,8 - 40,U/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,GGT,,26,,,,,10 - 61,U/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 488,umol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Calcium (EDTA),,2.52,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Phosphorus,,1.20,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Albumin-BCG,,53,,H,,,33 - 49,g/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Creatine Kinase,,70,,,,,39 - 308,U/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Bicarbonate,,25.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.99,,,,,1.42 - 2.08,mL/sec
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,86,,,,,40 - 110,umol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,81.1,,,,,kg,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,GFR,EGFR by MDRD,,87,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.94,,,,,1.9 - 23,uIU/mL
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Direct HDL-C 4th Generation,,0.90,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Triglycerides (GPO),,1.55,,,,,0.56 - 3.62,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,Cholesterol (High Performance),,4.40,,,,,3.88 - 6.83,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,LIPID PANEL,LDL Chol Friedewald 4th,,2.79,,,,,0 - 3.34,mmol/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,RETICULOCYTES,Reticulocyte Count %,,,,,Test cancelled: Clotted Blood Received,,,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,TSH,TSH 3rd IS-QT,,0.855,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110012,,,37,years,Male,Part 1 Screening,,"Mar 6, 2026 9:22 AM",6227797407,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,C-REACTIVE PROTEIN,C Reactive Protein HS,,12.0,,H,,,0 - 5,mg/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.7,,,,,0 - 6.2,umol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Alkaline Phosphatase,,120,,,,,40 - 129,U/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,ALT (SGPT),,15,,,,,5 - 48,U/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,AST (SGOT),,20,,,,,8 - 40,U/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,GGT,,15,,,,,10 - 50,U/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Glucose Fasting,,5.7,,H,,,3.9 - 5.6,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Uric Acid,,237,,,,,149 - 494,umol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Phosphorus,,0.98,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Total Protein,,84,,H,,,60 - 80,g/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Creatine Kinase,,116,,,,,39 - 308,U/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Sodium,,138,,,,,135 - 145,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Bicarbonate,,17.8,,L,,,19.3 - 29.3,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.23,,L,,,1.42 - 2.08,mL/sec
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,108,,,,,40 - 119,umol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,82.0,,,,,kg,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,GFR,EGFR by MDRD,,60,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,125 - 170,g/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.37 - 0.51,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.1,,,,,4 - 5.8,TI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,80 - 100,fL
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,9.37,,,,,3.8 - 10.7,GI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,6.83,,,,,1.96 - 7.23,GI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.79,,,,,0.8 - 3,GI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.61,,,,,0.12 - 0.92,GI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,72.9,,,,,40.5 - 75,%
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,19.1,,,,,15.4 - 48.5,%
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,%
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,%
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,%
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,509,R,H,,,130 - 394,GI/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.5,,H,,,<6.5 %,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.10,,,,,1.9 - 23,uIU/mL
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Direct HDL-C 4th Generation,,1.24,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Triglycerides (GPO),,1.36,,,,,0.65 - 2.94,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,Cholesterol (High Performance),,3.73,,L,,,4.53 - 7.71,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,LIPID PANEL,LDL Chol Friedewald 4th,,1.87,,,,,0 - 3.34,mmol/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,%
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,TSH,TSH 3rd IS-QT,,1.311,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1.01 - 1.03,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110011,,,61,years,Male,Part 1 Screening,,"Mar 2, 2026 9:05 AM",6227797408,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.5,,,,,0 - 5,mg/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Total Bilirubin,,15,,,,,3 - 21,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,4.7,,,,,0 - 6.2,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,40 - 129,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,5 - 48,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,GGT,,13,,,,,10 - 61,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Urea Nitrogen,,4.9,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,90,,,,,40 - 110,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Uric Acid,,287,,,,,125 - 488,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Calcium (EDTA),,2.55,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Phosphorus,,1.09,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Albumin-BCG,,51,,H,,,33 - 49,g/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Creatine Kinase,,332,,H,,,39 - 308,U/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Potassium,,3.9,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.60,,,,,1.42 - 2.08,mL/sec
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,90,,,,,40 - 110,umol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,61.0,,,,,kg,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,GFR,EGFR by MDRD,,89,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,149,,,,,127 - 181,g/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.39 - 0.54,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.9,,,,,4.5 - 6.4,TI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.69,,,,,3.8 - 10.7,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.98,,,,,1.96 - 7.23,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.11,,,,,0.91 - 4.28,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.45,,,,,0.12 - 0.92,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.06,,,,,0 - 0.57,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.10,,,,,0 - 0.2,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,74.5,,,,,40.5 - 75,%
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,16.5,,,,,15.4 - 48.5,%
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.8,,,,,2.6 - 10.1,%
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,%
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,%
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,262,,,,,140 - 400,GI/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.81,,,,,1.9 - 23,uIU/mL
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,%
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,TSH,TSH 3rd IS-QT,,0.928,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Specific Gravity,,1.009,,,,,1 - 1.04,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110010,,,25,years,Male,Part 1 Screening,,"Feb 17, 2026 11:03 AM",6227797406,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,C-REACTIVE PROTEIN,C Reactive Protein HS,,4.4,,,,,0 - 5,mg/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.3,,,,,0 - 6.2,umol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Alkaline Phosphatase,,67,,,,,35 - 104,U/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,ALT (SGPT),,28,,,,,4 - 43,U/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,AST (SGOT),,30,,,,,8 - 40,U/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,GGT,,27,,,,,4 - 49,U/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,LDH,,166,,,,,53 - 234,U/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Urea Nitrogen,,4.7,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,76,,,,,31 - 101,umol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Uric Acid,,337,,,,,149 - 446,umol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Calcium (EDTA),,2.51,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Phosphorus,,1.16,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Creatine Kinase,,148,,,,,26 - 192,U/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,145,,,,,116 - 164,g/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.43,,,,,0.34 - 0.48,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,8.09,,,,,3.8 - 10.7,GI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.49,,,,,1.96 - 7.23,GI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.02,,,,,0.91 - 4.28,GI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,55.6,,,,,40.5 - 75,%
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,37.4,,,,,15.4 - 48.5,%
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.0,,,,,2.6 - 10.1,%
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,%
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,%
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,316,,,,,140 - 400,GI/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.12,,,,,1.9 - 23,uIU/mL
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Direct HDL-C 4th Generation,,1.96,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Triglycerides (GPO),,1.32,,,,,0.59 - 2.96,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,Cholesterol (High Performance),,5.64,,,,,4.42 - 7.53,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,LIPID PANEL,LDL Chol Friedewald 4th,,3.08,,,,,0 - 3.34,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,RETICULOCYTES,Reticulocyte Count %,,0.6,,,,,0.6 - 2.5,%
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Specific Gravity,,1.021,,,,,1 - 1.04,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 2 OL Induction Day 29,,"Feb 16, 2026 9:18 AM",6226550646,URINE MICRO PANEL,Ur Microscopic,,Negative,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.0,,,,,0 - 5,mg/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Alkaline Phosphatase,,90,,,,,35 - 104,U/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,AST (SGOT),,15,,,,,8 - 40,U/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,LDH,,150,,,,,53 - 234,U/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,61,,,,,31 - 101,umol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Uric Acid,,250,,,,,125 - 428,umol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Calcium (EDTA),,2.30,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Phosphorus,,1.08,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Creatine Kinase,,69,,,,,26 - 192,U/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Potassium,,4.9,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Bicarbonate,,23.4,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.73,,,,,3.8 - 10.7,GI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.57,,,,,1.96 - 7.23,GI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.54,,,,,0.91 - 4.28,GI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.42,,,,,0.12 - 0.92,GI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.1,,,,,40.5 - 75,%
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,%
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,%
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.9,,,,,0 - 6.8,%
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,%
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,348,,,,,140 - 400,GI/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.60,,,,,1.9 - 23,uIU/mL
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Direct HDL-C 4th Generation,,1.10,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Triglycerides (GPO),,1.17,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,Cholesterol (High Performance),,4.41,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,LIPID PANEL,LDL Chol Friedewald 4th,,2.77,,,,,0 - 3.34,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,%
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Specific Gravity,,1.026,,,,,1 - 1.04,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 2 OL Induction Day 29,,"Feb 3, 2026 10:23 AM",6226561517,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CELLULAR ELEMENTS,Ur WBC/HPF,,4,,,,,0 - 12,/HPF
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Total Bilirubin,,<3,,L,,Result verified by repeat analysis,3 - 21,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.5,,,,,0 - 6.2,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,ALT (SGPT),,11,,,,,4 - 43,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,GGT,,16,,,,,4 - 49,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,LDH,,128,,,,,53 - 234,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Urea Nitrogen,,7.9,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,84,,,,,31 - 101,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Uric Acid,,250,,,,,125 - 428,umol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Calcium (EDTA),,2.33,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Phosphorus,,0.97,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,123,,,,,116 - 164,g/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.1,,,,,4.1 - 5.6,TI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.99,,,,,3.8 - 10.7,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.90,,L,,,1.96 - 7.23,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.18,,,,,0.12 - 0.92,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,47.6,,,,,40.5 - 75,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,43.6,,,,,15.4 - 48.5,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,4.5,,,,,2.6 - 10.1,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.8,,,,,0 - 6.8,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,301,,,,,140 - 400,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.6,,,,,<6.5 %,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.63,,,,,1.9 - 23,uIU/mL
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Direct HDL-C 4th Generation,,1.75,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Triglycerides (GPO),,0.50,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,Cholesterol (High Performance),,4.64,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,LIPID PANEL,LDL Chol Friedewald 4th,,2.66,,,,,0 - 3.34,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,TSH,TSH 3rd IS-QT,,1.963,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Blood,,+1,,H,,,Ref Rng:$Negative-Trace,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Jan 30, 2026 8:36 AM",6227498380,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.5,,,,,0 - 5,mg/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Alkaline Phosphatase,,52,,,,,40 - 129,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,ALT (SGPT),,77,,H RX,,,5 - 48,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,AST (SGOT),,49,,H,,,8 - 40,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,GGT,,53,,H,,,10 - 50,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,LDH,,139,,,,,53 - 234,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 119,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Glucose Fasting,,6.3,,H,,,3.9 - 5.6,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Uric Acid,,507,,H,,,149 - 494,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Calcium (EDTA),,2.38,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Phosphorus,,0.92,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Total Protein,,74,,,,,60 - 80,g/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Albumin-BCG,,46,,,,,33 - 49,g/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Creatine Kinase,,201,,,,,39 - 308,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Sodium,,140,,,,,135 - 145,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Potassium,,4.0,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Bicarbonate,,27.8,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,125 - 170,g/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.37 - 0.51,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,3.9,,L,,,4 - 5.8,TI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,96,,,,,80 - 100,fL
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.20,,,,,3.8 - 10.7,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.39,,,,,1.96 - 7.23,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.38,,,,,0.8 - 3,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.33,,,,,0.12 - 0.92,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.04,,,,,0 - 0.57,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.0,,,,,40.5 - 75,%
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,32.9,,,,,15.4 - 48.5,%
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.8,,,,,2.6 - 10.1,%
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.1,,,,,0 - 6.8,%
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.2,,,,,0 - 2,%
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,144,,,,,140 - 400,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,22.36,,,,,1.9 - 23,uIU/mL
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Direct HDL-C 4th Generation,,0.75,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Triglycerides (GPO),,3.00,,,,,0.65 - 3.61,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,Cholesterol (High Performance),,4.63,,,,,4.4 - 7.53,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,LIPID PANEL,LDL Chol Friedewald 4th,,2.51,,,,,0 - 3.34,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,%
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Specific Gravity,,1.010,,,,,1.01 - 1.03,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 DB Baseline,,"Jan 27, 2026 8:25 AM",6227144560,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Alkaline Phosphatase,,39,,,,,35 - 104,U/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,ALT (SGPT),,7,,,,,4 - 43,U/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,GGT,,10,,,,,4 - 49,U/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,LDH,,144,,,,,53 - 234,U/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Urea Nitrogen,,2.9,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Uric Acid,,162,,,,,125 - 428,umol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Calcium (EDTA),,2.41,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Phosphorus,,0.94,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Creatine Kinase,,56,,,,,26 - 192,U/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Sodium,,142,,,,,132 - 147,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Bicarbonate,,26.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.79,,,,,1.25 - 1.92,mL/sec
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,63,,,,,31 - 101,umol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,70.3,,,,,kg,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,GFR,EGFR by MDRD,,88,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,Result verified by repeat analysis,116 - 164,g/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,Result verified by repeat analysis,4.1 - 5.6,TI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.80,,,,Result verified by repeat analysis,3.8 - 10.7,GI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.45,,,,Result verified by repeat analysis,1.96 - 7.23,GI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.67,,,,,0.91 - 4.28,GI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.43,,,,Result verified by repeat analysis,0.12 - 0.92,GI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,Result verified by repeat analysis,0 - 0.57,GI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,Result verified by repeat analysis,0 - 0.2,GI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.1,,,,Result verified by repeat analysis,40.5 - 75,%
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.7,,,,Result verified by repeat analysis,15.4 - 48.5,%
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,9.0,,,,Result verified by repeat analysis,2.6 - 10.1,%
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.4,,,,Result verified by repeat analysis,0 - 6.8,%
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,Result verified by repeat analysis,0 - 2,%
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,254,,,,Result verified by repeat analysis,140 - 400,GI/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.02,,,,,1.9 - 23,uIU/mL
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Direct HDL-C 4th Generation,,1.67,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Triglycerides (GPO),,0.69,,,,,0.51 - 2.42,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,Cholesterol (High Performance),,5.79,,,,,4.01 - 6.85,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,LIPID PANEL,LDL Chol Friedewald 4th,,3.80,,H,,,0 - 3.34,mmol/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,RETICULOCYTES,Reticulocyte Count %,,1.2,,,,,0.6 - 2.5,%
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,TSH,TSH 3rd IS-QT,,1.837,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Specific Gravity,,1.005,,,,,1 - 1.04,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110009,,,48,years,Female,Part 1 Screening,,"Jan 21, 2026 10:11 AM",6227542160,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.9,,,,,0 - 5,mg/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CELLULAR ELEMENTS,Ur RBC/HPF,,3,,,,,0 - 8,/HPF
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CELLULAR ELEMENTS,Ur WBC/HPF,,1,,,,,0 - 12,/HPF
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,ALT (SGPT),,23,,,,,4 - 43,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,GGT,,21,,,,,4 - 49,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Uric Acid,,286,,,,,149 - 446,umol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Calcium (EDTA),,2.43,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Total Protein,,76,,,,,61 - 84,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Creatine Kinase,,147,,,,,26 - 192,U/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Bicarbonate,,22.4,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,FREE T4,Free Thyroxine-QT,,9,,,,,8 - 14,pmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,143,,,,,116 - 164,g/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,92,,,,,79 - 98,fL
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.42,,,,,3.8 - 10.7,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.84,,,,,1.96 - 7.23,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.08,,,,,0.91 - 4.28,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,51.8,,,,,40.5 - 75,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.6,,,,,15.4 - 48.5,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.9,,,,,2.6 - 10.1,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.8,,,,,0 - 6.8,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,332,,,,,140 - 400,GI/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.2,,,,,<6.5 %,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.98,,,,,1.9 - 23,uIU/mL
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Direct HDL-C 4th Generation,,2.01,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Triglycerides (GPO),,1.43,,,,,0.59 - 2.96,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,Cholesterol (High Performance),,5.46,,,,,4.42 - 7.53,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,LIPID PANEL,LDL Chol Friedewald 4th,,2.80,,,,,0 - 3.34,mmol/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,%
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,TSH,TSH 3rd IS-QT,,6.224,,H SF,,,0.45 - 5.33,mIU/L
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Specific Gravity,,1.033,,,,,1 - 1.04,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,End of Phase/Treatment,,"Jan 16, 2026 8:48 AM",6227542173,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.0,,,,,0 - 6.2,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Alkaline Phosphatase,,73,,,,,35 - 104,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,AST (SGOT),,13,,,,,8 - 40,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,GGT,,7,,,,,4 - 49,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,LDH,,145,,,,,53 - 234,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,56,,,,,31 - 101,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Uric Acid,,236,,,,,125 - 428,umol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Phosphorus,,1.19,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Creatine Kinase,,72,,,,,26 - 192,U/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Bicarbonate,,23.8,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.59,,,,,3.8 - 10.7,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.25,,,,,1.96 - 7.23,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.64,,,,,0.91 - 4.28,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.37,,,,,0.12 - 0.92,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.19,,,,,0 - 0.2,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.5,,,,,40.5 - 75,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,24.9,,,,,15.4 - 48.5,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.0,,,,,0 - 6.8,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.9,,H,,,0 - 2,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,300,,,,,140 - 400,GI/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,4.9,,,,,<6.5 %,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.92,,,,,1.9 - 23,uIU/mL
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Direct HDL-C 4th Generation,,1.01,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Triglycerides (GPO),,1.05,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,Cholesterol (High Performance),,3.68,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,LIPID PANEL,LDL Chol Friedewald 4th,,2.19,,,,,0 - 3.34,mmol/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,RETICULOCYTES,Reticulocyte Count %,,1.8,,,,,0.6 - 2.5,%
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,TSH,TSH 3rd IS-QT,,1.385,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,End of Phase/Treatment,R,"Jan 6, 2026 10:11 AM",6227261836,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,C-REACTIVE PROTEIN,C Reactive Protein HS,,8.1,,H,,,0 - 5,mg/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Alkaline Phosphatase,,51,,,,,40 - 129,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,ALT (SGPT),,79,,H RX,,,5 - 48,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,AST (SGOT),,51,,H,,,8 - 40,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,GGT,,52,,H,,,10 - 50,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,LDH,,160,,,,,53 - 234,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 119,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Glucose Fasting,,6.1,,H,,,3.9 - 5.6,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Uric Acid,,521,,H,,,149 - 494,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Calcium (EDTA),,2.37,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Phosphorus,,1.00,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Total Protein,,75,,,,,60 - 80,g/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Creatine Kinase,,206,,,,,39 - 308,U/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Sodium,,139,,,,,135 - 145,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Bicarbonate,,25.6,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.95,,,,,1.42 - 2.08,mL/sec
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,92,,,,,40 - 119,umol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,108.0,,,,,kg,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,GFR,EGFR by MDRD,,73,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,132,,,,,125 - 170,g/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.37 - 0.51,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.0,,,,,4 - 5.8,TI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,97,,,,,80 - 100,fL
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.10,,,,,3.8 - 10.7,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.77,,,,,1.96 - 7.23,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.71,,,,,0.8 - 3,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.52,,,,,0.12 - 0.92,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.05,,,,,0 - 0.57,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,61.7,,,,,40.5 - 75,%
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,28.1,,,,,15.4 - 48.5,%
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.5,,,,,2.6 - 10.1,%
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,0.9,,,,,0 - 6.8,%
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,%
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,178,,,,,140 - 400,GI/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,6.2,,,,,<6.5 %,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,15.17,,,,,1.9 - 23,uIU/mL
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Direct HDL-C 4th Generation,,0.74,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Triglycerides (GPO),,2.04,,,,,0.65 - 3.61,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,Cholesterol (High Performance),,4.38,,L,,,4.4 - 7.53,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,RETICULOCYTES,Reticulocyte Count %,,1.9,,,,,0.6 - 2.5,%
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,TSH,TSH 3rd IS-QT,,1.243,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Specific Gravity,,1.013,,,,,1.01 - 1.03,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110008,,,59,years,Male,Part 1 Screening,,"Jan 5, 2026 10:58 AM",6227542161,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Alkaline Phosphatase,,93,,,,,40 - 129,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,ALT (SGPT),,128,,H RX,,,5 - 48,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,AST (SGOT),,54,,H,,,8 - 40,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,GGT,,247,,H,,Result verified by repeat analysis,10 - 61,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,89,,,,,40 - 110,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Uric Acid,,430,,,,,125 - 488,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Phosphorus,,1.25,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Albumin-BCG,,48,,,,,33 - 49,g/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Creatine Kinase,,127,,,,,39 - 308,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,162,,,,,127 - 181,g/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.78,,,,,3.8 - 10.7,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.00,,,,,1.96 - 7.23,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.31,,,,,0.91 - 4.28,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.26,,,,,0.12 - 0.92,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.04,,,,,0 - 0.2,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.8,,,,,40.5 - 75,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.5,,,,,15.4 - 48.5,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.9,,,,,0 - 2,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,271,,,,,140 - 400,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.1,,,,,<6.5 %,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,8.27,,,,,1.9 - 23,uIU/mL
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Direct HDL-C 4th Generation,,1.32,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Triglycerides (GPO),,2.24,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,Cholesterol (High Performance),,5.39,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,LIPID PANEL,LDL Chol Friedewald 4th,,3.04,,,,,0 - 3.34,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,TSH,TSH 3rd IS-QT,,1.417,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Jan 2, 2026 9:28 AM",6227498379,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Alkaline Phosphatase,,63,,,,,35 - 104,U/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,ALT (SGPT),,18,,,,,4 - 43,U/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,GGT,,15,,,,,4 - 49,U/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,LDH,,142,,,,,53 - 234,U/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Urea Nitrogen,,4.2,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,81,,,,,31 - 101,umol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Glucose Fasting,,5.2,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Uric Acid,,291,,,,,125 - 428,umol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Total Protein,,70,,,,,61 - 84,g/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Creatine Kinase,,109,,,,,26 - 192,U/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Potassium,,4.1,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Bicarbonate,,21.7,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.55,,,,,1.25 - 1.92,mL/sec
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,81,,,,,31 - 101,umol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.0,,,,,kg,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,FSH,Follicle Stimulating Hormone,,1.95,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,124,,,,,116 - 164,g/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.37,,,,,0.34 - 0.48,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.35,,,,,3.8 - 10.7,GI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.19,,,,,1.96 - 7.23,GI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.57,,,,,0.91 - 4.28,GI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.6,,,,,40.5 - 75,%
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.4,,,,,15.4 - 48.5,%
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.3,,,,,2.6 - 10.1,%
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,%
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,%
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,340,,,,,140 - 400,GI/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.7,,,,,<6.5 %,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.35,,,,,1.9 - 23,uIU/mL
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Direct HDL-C 4th Generation,,1.82,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Triglycerides (GPO),,0.63,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,Cholesterol (High Performance),,5.11,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,LIPID PANEL,LDL Chol Friedewald 4th,,3.00,,,,,0 - 3.34,mmol/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,RETICULOCYTES,Reticulocyte Count %,,0.7,,,,,0.6 - 2.5,%
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,TSH,TSH 3rd IS-QT,,2.024,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Retest,R,"Dec 11, 2025 9:05 AM",6226935606,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.7,,,,,0 - 5,mg/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Total Bilirubin,,7,,,,,3 - 21,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Alkaline Phosphatase,,62,,,,,35 - 104,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,ALT (SGPT),,21,,,,,4 - 43,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,AST (SGOT),,24,,,,,8 - 40,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,GGT,,33,,,,,4 - 49,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,LDH,,158,,,,,53 - 234,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Urea Nitrogen,,4.1,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,73,,,,,31 - 101,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Glucose Fasting,,4.2,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Uric Acid,,307,,,,,149 - 446,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Total Protein,,71,,,,,61 - 84,g/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Creatine Kinase,,203,,H,,,26 - 192,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Bicarbonate,,22.0,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.49,,,,,3.8 - 10.7,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.93,,,,,1.96 - 7.23,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.72,,,,,0.91 - 4.28,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.32,,,,,0 - 0.57,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.17,,,,,0 - 0.2,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,45.2,,,,,40.5 - 75,%
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,41.9,,,,,15.4 - 48.5,%
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.3,,,,,2.6 - 10.1,%
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.9,,,,,0 - 6.8,%
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.7,R,H,,,0 - 2,%
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,332,,,,,140 - 400,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,3.15,,,,,1.9 - 23,uIU/mL
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Direct HDL-C 4th Generation,,1.91,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Triglycerides (GPO),,1.28,,,,,0.59 - 2.96,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,Cholesterol (High Performance),,5.21,,,,,4.42 - 7.53,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,LIPID PANEL,LDL Chol Friedewald 4th,,2.71,,,,,0 - 3.34,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,%
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 DB Baseline,,"Dec 11, 2025 8:13 AM",6227144562,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,C-REACTIVE PROTEIN,C Reactive Protein HS,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Total Bilirubin,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Alkaline Phosphatase,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,ALT (SGPT),,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,AST (SGOT),,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,GGT,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,LDH,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Urea Nitrogen,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Glucose Fasting,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Uric Acid,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Calcium (EDTA),,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Phosphorus,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Total Protein,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Albumin-BCG,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Creatine Kinase,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Sodium,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Potassium,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Bicarbonate,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,CHEMISTRY PANEL,Serum Chloride,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,126,,,,,116 - 164,g/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.3,,,,,4.1 - 5.6,TI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.49,,,,,3.8 - 10.7,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.37,,,,,1.96 - 7.23,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.07,,,,,0 - 0.57,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,52.8,,,,,40.5 - 75,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,38.7,,,,,15.4 - 48.5,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.5,,,,,2.6 - 10.1,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,299,,,,,140 - 400,GI/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,HEMOGLOBIN A1C,"Hemoglobin A1c,NGSP-RM",,5.5,,,,,<6.5 %,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.65,,,,,1.9 - 23,uIU/mL
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Direct HDL-C 4th Generation,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Triglycerides (GPO),,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,Cholesterol (High Performance),,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,LIPID PANEL,LDL Chol Friedewald 4th,,Required testing unavailable,,,,,0 - 3.34,mmol/L
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,%
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,TSH,TSH 3rd IS-QT,,,,,"Test cancelled: Expired contain, test cancel",,,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,End of Phase/Treatment,,"Dec 5, 2025 9:23 AM",6225351093,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CELLULAR ELEMENTS,Ur WBC/HPF,,5,,,,,0 - 12,/HPF
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CELLULAR ELEMENTS,Ur Squamous Epithelial Cells,,80,,,,,0 - 3,/HPF
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Alkaline Phosphatase,,98,,,,,35 - 104,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,ALT (SGPT),,8,,,,,4 - 43,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,AST (SGOT),,10,,,,,8 - 40,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,GGT,,8,,,,,4 - 49,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,LDH,,142,,,,,53 - 234,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Urea Nitrogen,,4.8,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,62,,,,,31 - 101,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Uric Acid,,261,,,,,125 - 428,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Phosphorus,,1.10,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Creatine Kinase,,42,,,,,26 - 192,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Bicarbonate,,21.8,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,CRYSTALS,Ur Calcium Oxalate Crystals,,Present,,,,,Ref Rng:Not present,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,136,,,,,116 - 164,g/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 98,fL
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.82,,,,,3.8 - 10.7,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,5.12,,,,,1.96 - 7.23,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,2.07,,,,,0.91 - 4.28,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.08,,,,,0 - 0.2,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,65.4,,,,,40.5 - 75,%
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.4,,,,,15.4 - 48.5,%
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,%
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.1,,,,,0 - 6.8,%
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,%
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,322,,,,,140 - 400,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.28,,,,,1.9 - 23,uIU/mL
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Direct HDL-C 4th Generation,,1.25,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Triglycerides (GPO),,0.86,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,Cholesterol (High Performance),,4.48,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,LIPID PANEL,LDL Chol Friedewald 4th,,2.84,,,,,0 - 3.34,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,MISCELLANEOUS ELEMENTS,Ur Mucous,,Present,,,,,Ref Rng:Not present,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,RETICULOCYTES,Reticulocyte Count %,,2.1,,,,,0.6 - 2.5,%
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Specific Gravity,,1.037,,H,,,1 - 1.04,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 DB Baseline,,"Nov 25, 2025 10:04 AM",6227144561,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,,0 - 5,mg/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.6,,,,,0 - 6.2,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Alkaline Phosphatase,,100,,,,,35 - 104,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,ALT (SGPT),,20,,,,,4 - 43,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,AST (SGOT),,25,,,,,8 - 40,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,GGT,,63,,H,,,4 - 49,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,LDH,,174,,,,,53 - 234,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Uric Acid,,291,,,,,149 - 446,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Calcium (EDTA),,2.42,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Phosphorus,,1.02,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,26 - 192,U/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.17,,L,,,1.25 - 1.92,mL/sec
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,75,,,,,31 - 101,umol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,59.2,,,,,kg,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,FREE T4,Free Thyroxine-QT,,9,,,,,8 - 14,pmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,GFR,EGFR by MDRD,,69,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,140,,,,,116 - 164,g/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.41,,,,,0.34 - 0.48,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.6,,,,,4.1 - 5.6,TI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 98,fL
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.44,,,,,3.8 - 10.7,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.83,,,,,1.96 - 7.23,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,4.07,,,,,0.91 - 4.28,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.21,,,,,0 - 0.57,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,38.0,R,L,,,40.5 - 75,%
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,54.7,R,H,,,15.4 - 48.5,%
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,3.8,,,,,2.6 - 10.1,%
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.8,,,,,0 - 6.8,%
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.6,,,,,0 - 2,%
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,295,,,,,140 - 400,GI/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,2.96,,,,,1.9 - 23,uIU/mL
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Direct HDL-C 4th Generation,,1.84,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Triglycerides (GPO),,1.42,,,,,0.59 - 2.96,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,Cholesterol (High Performance),,5.78,,,,,4.42 - 7.53,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,LIPID PANEL,LDL Chol Friedewald 4th,,3.29,,,,,0 - 3.34,mmol/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,%
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,TSH,TSH 3rd IS-QT,,5.438,R,H SF,,,0.45 - 5.33,mIU/L
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Specific Gravity,,1.017,,,,,1 - 1.04,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110007,,,56,years,Female,Part 1 Screening,,"Nov 14, 2025 10:22 AM",6225351078,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,,0 - 5,mg/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.9,,,,,0 - 6.2,umol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Alkaline Phosphatase,,84,,,,,40 - 129,U/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,ALT (SGPT),,64,,H,,,5 - 48,U/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,AST (SGOT),,27,,,,,8 - 40,U/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,GGT,,123,,H,,,10 - 61,U/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,LDH,,159,,,,,53 - 234,U/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Urea Nitrogen,,6.3,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Uric Acid,,419,,,,,125 - 488,umol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Calcium (EDTA),,2.53,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Phosphorus,,1.27,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Total Protein,,73,,,,,61 - 84,g/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Creatine Kinase,,141,,,,,39 - 308,U/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Bicarbonate,,21.9,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,CHEMISTRY PANEL,Serum Chloride,,104,,,,,94 - 112,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.44,,,,,0.39 - 0.54,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.0,,,,,4.5 - 6.4,TI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.88,,,,,3.8 - 10.7,GI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.07,,,,,1.96 - 7.23,GI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.32,,,,,0.91 - 4.28,GI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.15,,,,,0 - 0.57,GI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,62.9,,,,,40.5 - 75,%
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.1,,,,,15.4 - 48.5,%
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.9,,,,,2.6 - 10.1,%
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.0,,,,,0 - 6.8,%
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,%
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,266,,,,,140 - 400,GI/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,6.45,,,,,1.9 - 23,uIU/mL
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Triglycerides (GPO),,1.73,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,Cholesterol (High Performance),,4.62,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,LIPID PANEL,LDL Chol Friedewald 4th,,2.91,,,,,0 - 3.34,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,RETICULOCYTES,Reticulocyte Count %,,1.4,,,,,0.6 - 2.5,%
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 2 OL Induction Day 29,,"Nov 6, 2025 8:14 AM",6226991311,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,C-REACTIVE PROTEIN,C Reactive Protein HS,,5.3,,H,,,0 - 5,mg/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.6,,,,,0 - 6.2,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Alkaline Phosphatase,,101,,,,,35 - 104,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,AST (SGOT),,12,,,,,8 - 40,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,GGT,,6,,,,,4 - 49,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,LDH,,157,,,,,53 - 234,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Urea Nitrogen,,3.7,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Uric Acid,,232,,,,,125 - 428,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Calcium (EDTA),,2.27,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Creatine Kinase,,59,,,,,26 - 192,U/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Sodium,,136,,,,,132 - 147,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.50,,H,,,1.25 - 1.92,mL/sec
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,57,,,,,31 - 101,umol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.2,,,,,kg,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,GFR,EGFR by MDRD,,108,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,4.1 - 5.6,TI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 98,fL
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,7.26,,,,,3.8 - 10.7,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,4.66,,,,,1.96 - 7.23,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.98,,,,,0.91 - 4.28,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.40,,,,,0.12 - 0.92,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.17,,,,,0 - 0.57,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,64.1,,,,,40.5 - 75,%
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.4,,,,,15.4 - 48.5,%
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.4,,,,,2.6 - 10.1,%
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,%
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.8,,,,,0 - 2,%
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,335,,,,,140 - 400,GI/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.40,,,,,1.9 - 23,uIU/mL
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Direct HDL-C 4th Generation,,0.99,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Triglycerides (GPO),,0.76,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,Cholesterol (High Performance),,4.01,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,LIPID PANEL,LDL Chol Friedewald 4th,,2.67,,,,,0 - 3.34,mmol/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,MICROORGANISMS,Ur Bacteria,,Present,,,,,Ref Rng:Not present,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,RETICULOCYTES,Reticulocyte Count %,,2.4,,,,,0.6 - 2.5,%
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,TSH,TSH 3rd IS-QT,,1.593,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MACRO PANEL,Ur Leukocyte Esterase,,+1,,H,,,Ref Rng:Negative,
|
|
CZ100110006,,,32,years,Female,Part 1 Screening,,"Nov 4, 2025 7:03 AM",6225351080,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,BENZODIAZEPINE CONFIRM. UR,BenzodiazepineConf-LCMSMS-LDT,,Oxazepam (Confirmed),R,RX,,,No Ref Rng,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.2,,,,,0 - 5,mg/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Total Bilirubin,,4,,,,,3 - 21,umol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,1.6,,,,,0 - 6.2,umol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,40 - 129,U/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,ALT (SGPT),,27,,,,,5 - 48,U/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,AST (SGOT),,23,,,,,8 - 40,U/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,GGT,,17,,,,,10 - 61,U/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,LDH,,161,,,,,53 - 234,U/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 110,umol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Glucose Fasting,,5.4,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Uric Acid,,344,,,,,125 - 488,umol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Calcium (EDTA),,2.46,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Total Protein,,78,,,,,61 - 84,g/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Creatine Kinase,,232,,,,,39 - 308,U/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Potassium,,4.7,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Bicarbonate,,21.3,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.37,,H,,,1.42 - 2.08,mL/sec
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,83,,,,,40 - 110,umol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,89.1,,,,,kg,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Detected (unconfirmed),,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,GFR,EGFR by MDRD,,93,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,141,,,,,127 - 181,g/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.39 - 0.54,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.5 - 6.4,TI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,86,,,,,79 - 96,fL
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.63,,,,,3.8 - 10.7,GI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.10,,,,,1.96 - 7.23,GI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,3.01,,,,,0.91 - 4.28,GI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.37,,,,,0.12 - 0.92,GI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.11,,,,,0 - 0.57,GI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.03,,,,,0 - 0.2,GI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,46.8,,,,,40.5 - 75,%
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,45.4,,,,,15.4 - 48.5,%
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.6,,,,,2.6 - 10.1,%
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,1.6,,,,,0 - 6.8,%
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.5,,,,,0 - 2,%
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,306,,,,,140 - 400,GI/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.3,,,,,<6.5%,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,16.63,,,,,1.9 - 23,uIU/mL
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Direct HDL-C 4th Generation,,0.95,R,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Triglycerides (GPO),,2.07,,,,,0.56 - 3.62,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,Cholesterol (High Performance),,5.65,,,,,3.88 - 6.83,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,LIPID PANEL,LDL Chol Friedewald 4th,,3.75,,H,,,0 - 3.34,mmol/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,%
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,TSH,TSH 3rd IS-QT,,2.249,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1 - 1.04,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur pH,,5.0,,,,,5 - 8,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110005,,,33,years,Male,Part 1 Screening,,"Nov 3, 2025 9:40 AM",6225351074,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.4,,,,Result verified by repeat analysis,0 - 5,mg/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.5,,,,,0 - 6.2,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Alkaline Phosphatase,,60,,,,,35 - 104,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,ALT (SGPT),,9,,,,,4 - 43,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,GGT,,13,,,,,4 - 49,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,LDH,,126,,,,,53 - 234,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Urea Nitrogen,,3.6,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,77,,,,,31 - 101,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Glucose Fasting,,5.0,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Uric Acid,,217,,,,,125 - 428,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Phosphorus,,1.01,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Total Protein,,66,,,,,61 - 84,g/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Creatine Kinase,,66,,,,,26 - 192,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Sodium,,141,,,,,132 - 147,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Bicarbonate,,24.5,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,121,,,,,116 - 164,g/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.05,,,,,3.8 - 10.7,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.88,,,,,1.96 - 7.23,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.73,,,,,0.91 - 4.28,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.13,,,,,0 - 0.57,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.1,,,,,40.5 - 75,%
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,34.3,,,,,15.4 - 48.5,%
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.7,,,,,2.6 - 10.1,%
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.6,,,,,0 - 6.8,%
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.4,,,,,0 - 2,%
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,286,,,,,140 - 400,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.08,,,,,1.9 - 23,uIU/mL
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Direct HDL-C 4th Generation,,1.85,R,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Triglycerides (GPO),,0.57,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,Cholesterol (High Performance),,4.35,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,LIPID PANEL,LDL Chol Friedewald 4th,,2.24,,,,,0 - 3.34,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,%
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Specific Gravity,,1.015,,,,,1 - 1.04,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 DB Baseline,,"Oct 22, 2025 8:04 AM",6225351084,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Total Bilirubin,,11,,,,,3 - 21,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Alkaline Phosphatase,,88,,,,,40 - 129,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,AST (SGOT),,21,,,,,8 - 40,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,GGT,,129,,H,,,10 - 61,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,LDH,,156,,,,,53 - 234,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Urea Nitrogen,,5.2,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,91,,,,,40 - 110,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Uric Acid,,429,,,,,125 - 488,umol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Calcium (EDTA),,2.56,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Phosphorus,,1.13,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Total Protein,,75,,,,,61 - 84,g/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Creatine Kinase,,131,,,,,39 - 308,U/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Sodium,,137,,,,,132 - 147,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Bicarbonate,,21.4,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,CHEMISTRY PANEL,Serum Chloride,,100,,,,,94 - 112,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,157,,,,,127 - 181,g/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.46,,,,,0.39 - 0.54,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,88,,,,,79 - 96,fL
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.79,,,,,3.8 - 10.7,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.75,,,,,1.96 - 7.23,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.48,,,,,0.91 - 4.28,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.14,,,,,0 - 0.57,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.07,,,,,0 - 0.2,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.9,,,,,15.4 - 48.5,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.2,,,,,2.6 - 10.1,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.9,,,,,0 - 6.8,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.5,,,,,0 - 2,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,280,,,,,140 - 400,GI/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,10.32,,,,,1.9 - 23,uIU/mL
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Direct HDL-C 4th Generation,,0.92,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Triglycerides (GPO),,1.99,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,Cholesterol (High Performance),,4.77,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,LIPID PANEL,LDL Chol Friedewald 4th,,2.94,,,,,0 - 3.34,mmol/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,RETICULOCYTES,Reticulocyte Count %,,1.3,,,,,0.6 - 2.5,%
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,TSH,TSH 3rd IS-QT,,1.125,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Specific Gravity,,1.023,,,,,1 - 1.04,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,End of Phase/Treatment,,"Oct 9, 2025 8:45 AM",6225351095,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.4,,,,,0 - 5,mg/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Total Bilirubin,,8,,,,,3 - 21,umol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.2,,,,,0 - 6.2,umol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Alkaline Phosphatase,,89,,,,,35 - 104,U/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,ALT (SGPT),,16,,,,,4 - 43,U/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,AST (SGOT),,14,,,,,8 - 40,U/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,GGT,,16,,,,,4 - 49,U/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,LDH,,124,,,,,53 - 234,U/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Urea Nitrogen,,4.5,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Glucose Fasting,,4.3,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Uric Acid,,303,,,,,125 - 428,umol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Calcium (EDTA),,2.40,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Phosphorus,,1.03,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Total Protein,,74,,,,,61 - 84,g/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Albumin-BCG,,47,,,,,33 - 49,g/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Sodium,,138,,,,,132 - 147,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Potassium,,4.4,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Bicarbonate,,23.6,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,CHEMISTRY PANEL,Serum Chloride,,102,,,,,94 - 112,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,127,,,,,116 - 164,g/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.39,,,,,0.34 - 0.48,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,83,,,,,79 - 98,fL
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.69,,,,,3.8 - 10.7,GI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.05,,,,,1.96 - 7.23,GI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.72,,,,,0.91 - 4.28,GI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.49,,,,,0.12 - 0.92,GI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.34,,,,,0 - 0.57,GI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.09,,,,,0 - 0.2,GI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,53.5,,,,,40.5 - 75,%
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.1,,,,,15.4 - 48.5,%
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,8.6,,,,,2.6 - 10.1,%
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,6.1,,,,,0 - 6.8,%
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.6,,,,,0 - 2,%
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,274,,,,,140 - 400,GI/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.2,,,,,<6.5%,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.14,,,,,1.9 - 23,uIU/mL
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Direct HDL-C 4th Generation,,1.48,,,,Result verified by repeat analysis,1.03 - 1.53,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Triglycerides (GPO),,0.82,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,Cholesterol (High Performance),,3.76,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,LIPID PANEL,LDL Chol Friedewald 4th,,1.90,,,,,0 - 3.34,mmol/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,%
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,TSH,TSH 3rd IS-QT,,1.582,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Specific Gravity,,1.011,,,,,1 - 1.04,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,End of Phase/Treatment,,"Oct 8, 2025 8:16 AM",6225351094,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.4,,,,,0 - 5,mg/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.3,,,,,0 - 6.2,umol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Alkaline Phosphatase,,80,,,,,35 - 104,U/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,ALT (SGPT),,32,,,,,4 - 43,U/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,AST (SGOT),,34,,,,,8 - 40,U/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,GGT,,25,,,,,5 - 50,U/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,LDH,,167,,,,,53 - 234,U/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Urea Nitrogen,,4.0,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Glucose Fasting,,4.8,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Uric Acid,,265,,,,,149 - 446,umol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Total Protein,,63,,,,,60 - 80,g/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Albumin-BCG,,43,,,,,33 - 49,g/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Creatine Kinase,,46,,,,,26 - 192,U/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Sodium,,143,,,,,135 - 145,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Bicarbonate,,24.9,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.74,,,,,1.25 - 1.92,mL/sec
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,58,,,,,31 - 101,umol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,75.3,,,,,kg,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,No,,,,,,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,GFR,EGFR by MDRD,,90,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,146,,,,,115 - 158,g/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.42,,,,,0.34 - 0.48,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.4,,,,,3.9 - 5.5,TI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,95,,,,,80 - 100,fL
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,3.39,R,L,,,3.8 - 10.7,GI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,1.95,R,L,,,1.96 - 7.23,GI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.01,,,,,0.8 - 3,GI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.24,,,,,0.12 - 0.92,GI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.16,,,,,0 - 0.57,GI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.02,,,,,0 - 0.2,GI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,57.5,,,,,40.5 - 75,%
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,29.8,,,,,15.4 - 48.5,%
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,%
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,4.8,,,,,0 - 6.8,%
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.7,,,,,0 - 2,%
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,169,,,,,130 - 394,GI/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.6,,,,,<6.5%,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.01,,,,,1.9 - 23,uIU/mL
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Direct HDL-C 4th Generation,,1.49,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Triglycerides (GPO),,0.88,,,,,0.63 - 2.71,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,Cholesterol (High Performance),,4.46,R,L,,,4.86 - 8.28,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,%
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,TSH,TSH 3rd IS-QT,,2.205,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Specific Gravity,,1.006,,,,,1.01 - 1.03,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110004,,,64,years,Female,Part 1 Screening,,"Oct 3, 2025 9:33 AM",6225351077,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,C-REACTIVE PROTEIN,C Reactive Protein HS,,1.0,,,,,0 - 5,mg/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Total Bilirubin,,9,,,,,3 - 21,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.5,,,,,0 - 6.2,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Alkaline Phosphatase,,61,,,,,35 - 104,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,ALT (SGPT),,13,,,,,4 - 43,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,AST (SGOT),,16,,,,,8 - 40,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,LDH,,137,,,,,53 - 234,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Urea Nitrogen,,4.3,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Glucose Fasting,,4.5,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Calcium (EDTA),,2.34,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Phosphorus,,1.07,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Total Protein,,69,,,,,61 - 84,g/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Creatine Kinase,,123,,,,,26 - 192,U/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Bicarbonate,,22.8,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,1.59,,,,,1.25 - 1.92,mL/sec
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,79,,,,,31 - 101,umol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,68.1,,,,,kg,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,GFR,EGFR by MDRD,,73,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,125,,,,,116 - 164,g/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.38,,,,,0.34 - 0.48,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.2,,,,,4.1 - 5.6,TI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,90,,,,,79 - 98,fL
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.30,,,,,3.8 - 10.7,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.33,,,,,1.96 - 7.23,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.57,,,,,0.91 - 4.28,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.01,,,,,0 - 0.2,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,54.1,,,,,40.5 - 75,%
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,36.6,,,,,15.4 - 48.5,%
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.7,,,,,2.6 - 10.1,%
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.3,,,,,0 - 6.8,%
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.3,,,,,0 - 2,%
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,140 - 400,GI/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.5,,,,,<6.5%,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,4.11,,,,,1.9 - 23,uIU/mL
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Direct HDL-C 4th Generation,,1.65,,H,,,1.03 - 1.53,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Triglycerides (GPO),,0.93,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,Cholesterol (High Performance),,4.65,,,,,3.65 - 6.21,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,LIPID PANEL,LDL Chol Friedewald 4th,,2.57,,,,,0 - 3.34,mmol/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,No,,,,,,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,RETICULOCYTES,Reticulocyte Count %,,0.9,,,,,0.6 - 2.5,%
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,TSH,TSH 3rd IS-QT,,3.025,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Specific Gravity,,1.014,,,,,1 - 1.04,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur pH,,6.5,,,,,5 - 8,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110003,,,35,years,Female,Part 1 Screening,,"Sep 26, 2025 9:10 AM",6225351081,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.3,,,,Result verified by repeat analysis,0 - 5,mg/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Total Bilirubin,,10,,,,,3 - 21,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.4,,,,,0 - 6.2,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Alkaline Phosphatase,,94,,,,,40 - 129,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,ALT (SGPT),,46,,,,,5 - 48,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,AST (SGOT),,18,,,,,8 - 40,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,GGT,,93,,H,,,10 - 61,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,LDH,,165,,,,,53 - 234,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Urea Nitrogen,,5.7,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,94,,,,,40 - 110,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Uric Acid,,427,,,,,125 - 488,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Phosphorus,,1.18,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Total Protein,,77,,,,,61 - 84,g/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Albumin-BCG,,49,,,,,33 - 49,g/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Creatine Kinase,,89,,,,,39 - 308,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Potassium,,4.3,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Bicarbonate,,21.0,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,CHEMISTRY PANEL,Serum Chloride,,101,,,,,94 - 112,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,165,,,,,127 - 181,g/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.47,,,,,0.39 - 0.54,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.2,,,,,4.5 - 6.4,TI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,Normocytic,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,89,,,,,79 - 96,fL
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,6.70,,,,,3.8 - 10.7,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.28,,,,,1.96 - 7.23,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.74,,,,,0.91 - 4.28,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,1.34,R,H,,,0 - 0.57,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.00,,,,,0 - 0.2,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,49.0,,,,,40.5 - 75,%
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,26.0,,,,,15.4 - 48.5,%
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,5.0,,,,,2.6 - 10.1,%
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,20.0,R,H,,,0 - 6.8,%
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,0.0,,,,,0 - 2,%
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,250,,,,,140 - 400,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,,,,Test cancelled: Hemolysis-test not performed,,,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Direct HDL-C 4th Generation,,0.77,,L,,Result verified by repeat analysis,1.03 - 1.53,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Triglycerides (GPO),,1.72,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,Cholesterol (High Performance),,4.31,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,LIPID PANEL,LDL Chol Friedewald 4th,,2.75,,,,,0 - 3.34,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,RETICULOCYTES,Reticulocyte Count %,,1.1,,,,,0.6 - 2.5,%
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Specific Gravity,,1.018,,,,,1 - 1.04,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 DB Baseline,,"Aug 28, 2025 11:45 AM",6225351082,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,C-REACTIVE PROTEIN,C Reactive Protein HS,,2.1,,,,,0 - 5,mg/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CELLULAR ELEMENTS,Ur WBC/HPF,,3,,,,,0 - 12,/HPF
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Total Bilirubin,,12,,,,,3 - 21,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.8,,,,,0 - 6.2,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Alkaline Phosphatase,,83,,,,,35 - 104,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,AST (SGOT),,11,,,,,8 - 40,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,LDH,,133,,,,,53 - 234,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Urea Nitrogen,,4.4,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,68,,,,,31 - 101,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Glucose Fasting,,4.7,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Uric Acid,,303,,,,,125 - 428,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Calcium (EDTA),,2.36,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Phosphorus,,1.06,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Albumin-BCG,,45,,,,,33 - 49,g/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Creatine Kinase,,79,,,,,26 - 192,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Potassium,,4.2,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Bicarbonate,,22.2,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,129,,,,,116 - 164,g/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.40,,,,,0.34 - 0.48,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.7,,,,,4.1 - 5.6,TI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,85,,,,,79 - 98,fL
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.56,,,,,3.8 - 10.7,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.30,,,,,1.96 - 7.23,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.54,,,,,0.91 - 4.28,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.39,,,,,0.12 - 0.92,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.20,,,,,0 - 0.57,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.11,,,,,0 - 0.2,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,59.4,,,,,40.5 - 75,%
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,27.9,,,,,15.4 - 48.5,%
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,7.1,,,,,2.6 - 10.1,%
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.6,,,,,0 - 6.8,%
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,2.0,,,,,0 - 2,%
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,255,,,,,140 - 400,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.14,,,,,1.9 - 23,uIU/mL
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Direct HDL-C 4th Generation,,1.22,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Triglycerides (GPO),,0.56,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,Cholesterol (High Performance),,3.42,,L,,,3.65 - 6.21,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,LIPID PANEL,LDL Chol Friedewald 4th,,1.94,,,,,0 - 3.34,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,RETICULOCYTES,Reticulocyte Count %,,0.8,,,,,0.6 - 2.5,%
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Specific Gravity,,1.029,,,,,1 - 1.04,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Protein,,Trace,,H,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Blood,,Trace,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MACRO PANEL,Ur Leukocyte Esterase,,Trace,,H,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 DB Baseline,,"Aug 28, 2025 7:07 AM",6225351083,URINE MICRO PANEL,Ur Microscopic,,Positive,,,,, NEGATIVE$,NEGATIVE
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,C-REACTIVE PROTEIN,C Reactive Protein HS,,0.2,,,,Result verified by repeat analysis,0 - 5,mg/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Total Bilirubin,,13,,,,,3 - 21,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,3.7,,,,,0 - 6.2,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Alkaline Phosphatase,,85,,,,,40 - 129,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,ALT (SGPT),,73,,H RX,,,5 - 48,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,AST (SGOT),,31,,,,,8 - 40,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,GGT,,149,,H,,,10 - 61,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,LDH,,171,,,,,53 - 234,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Urea Nitrogen,,6.0,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Glucose Fasting,,4.9,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Uric Acid,,469,,,,,125 - 488,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Calcium (EDTA),,2.57,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Phosphorus,,1.15,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Total Protein,,80,,,,,61 - 84,g/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Albumin-BCG,,50,,H,,,33 - 49,g/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Creatine Kinase,,138,,,,,39 - 308,U/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Sodium,,140,,,,,132 - 147,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Bicarbonate,,21.5,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CHEMISTRY PANEL,Serum Chloride,,103,,,,,94 - 112,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.14,,H,,,1.42 - 2.08,mL/sec
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,104,,,,,40 - 110,umol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,93.8,,,,,kg,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,GFR,EGFR by MDRD,,76,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,169,,,,,127 - 181,g/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,0.49,,,,,0.39 - 0.54,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,5.4,,,,,4.5 - 6.4,TI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,91,,,,,79 - 96,fL
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,4.17,,,,,3.8 - 10.7,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,2.44,,,,,1.96 - 7.23,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.28,,,,,0.91 - 4.28,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.29,,,,,0.12 - 0.92,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.10,,,,,0 - 0.57,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.06,,,,,0 - 0.2,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,58.4,,,,,40.5 - 75,%
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,30.7,,,,,15.4 - 48.5,%
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.9,,,,,2.6 - 10.1,%
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,2.5,,,,,0 - 6.8,%
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.4,,,,,0 - 2,%
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,259,,,,,140 - 400,GI/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,4.8,,,,,<6.5%,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,7.13,,,,,1.9 - 23,uIU/mL
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Direct HDL-C 4th Generation,,0.96,,L,,,1.03 - 1.53,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Triglycerides (GPO),,2.37,,,,,0.5 - 2.81,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,Cholesterol (High Performance),,5.50,,,,,3.31 - 6.1,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,LIPID PANEL,LDL Chol Friedewald 4th,,3.45,,H,,,0 - 3.34,mmol/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,%
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,TSH,TSH 3rd IS-QT,,2.030,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Specific Gravity,,1.019,,,,,1 - 1.04,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur pH,,6.0,,,,,5 - 8,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110002,,,25,years,Male,Part 1 Screening,,"Aug 6, 2025 9:40 AM",6225351072,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,C-REACTIVE PROTEIN,C Reactive Protein HS,,3.4,,,,,0 - 5,mg/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Total Bilirubin,,6,,,,,3 - 21,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Direct Bilirubin Gen2-Doumas,,2.4,,,,,0 - 6.2,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Alkaline Phosphatase,,77,,,,,35 - 104,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,ALT (SGPT),,10,,,,,4 - 43,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,AST (SGOT),,12,,,,,8 - 40,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,GGT,,14,,,,,4 - 49,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,LDH,,127,,,,,53 - 234,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Urea Nitrogen,,6.1,,,,,1.4 - 8.6,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Glucose Fasting,,4.6,,,,,3.9 - 5.6,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Uric Acid,,273,,,,,125 - 428,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Calcium (EDTA),,2.35,,,,,2.07 - 2.64,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Phosphorus,,1.14,,,,,0.71 - 1.65,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Total Protein,,72,,,,,61 - 84,g/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Albumin-BCG,,44,,,,,33 - 49,g/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Creatine Kinase,,88,,,,,26 - 192,U/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Sodium,,139,,,,,132 - 147,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Potassium,,4.5,,,,,3.5 - 5.2,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Bicarbonate,,21.2,,,,,19.3 - 29.3,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CHEMISTRY PANEL,Serum Chloride,,105,,,,,94 - 112,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,CreatininClearancCockcrftGault,,2.33,,H,,,1.25 - 1.92,mL/sec
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,Creatinine(Rate Blanked)-2dp,,65,,,,,31 - 101,umol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,CREATININE CLEARANCE CC&G,"Weight (kg,1dec place)",Y,79.2,,,,,kg,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Amphetamines/MDMA,,Neg,,,,,Neg;$Cutoff = 1000 ng/mL,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Barbiturates,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Cannabinoids,,Neg,,,,,Neg;$Cutoff = 50 ng/mL,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Cocaine,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Opiates,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE,Methadone,,Neg,,,,,Neg;$Cutoff = 300 ng/mL,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,DRUG SCREEN URINE BENZO NON-US,Benzodiazepines Gen 2,,Neg,,,,,Neg;$Cutoff = 200 ng/mL,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,FEMALE OF CHILDBEARING POT?,Female/of Childbearing pot.?,Y,Yes,,,,,,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,FSH,Follicle Stimulating Hormone,,3.55,,RX,,,Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,GFR,EGFR by MDRD,,92,,,,,mL/min/1.73m^2$No Ref Rng,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Hemoglobin,,128,,,,,116 - 164,g/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Hematocrit,,,,,Test cancelled: Beyond stability,,,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,RBC,,4.5,,,,,4.1 - 5.6,TI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,RBC Morphology,,No Review Required,,,,,NORMOCYTIC;$NORMOCHROMIC,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,MCV,,,,,Test cancelled: Beyond stability,,,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,WBC,,5.62,,,,,3.8 - 10.7,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils,,3.19,,,,,1.96 - 7.23,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes,,1.85,,,,,0.91 - 4.28,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes,,0.34,,,,,0.12 - 0.92,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils,,0.19,,,,,0 - 0.57,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils,,0.05,,,,,0 - 0.2,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Neutrophils (%),,56.7,,,,,40.5 - 75,%
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Lymphocytes (%),,33.0,,,,,15.4 - 48.5,%
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Monocytes (%),,6.0,,,,,2.6 - 10.1,%
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Eosinophils (%),,3.4,,,,,0 - 6.8,%
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Basophils (%),,1.0,,,,,0 - 2,%
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMATOLOGY&DIFFERENTIAL PANEL,Platelets,,253,,,,,140 - 400,GI/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,HEMOGLOBIN A1C,"Hemoglobin A1c,Variant(-70)-QT",,5.1,,,,,<6.5%,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,INSULIN,"Ultra.Insulin,EDTApl,FastingQT",,5.61,,,,,1.9 - 23,uIU/mL
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,IS SUBJECT FASTING?,Is Subject Fasting?,Y,Yes,,,,,,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,IS SUBJECT OF BLACK RACE?,Subject of black race?,Y,No,,,,,,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Direct HDL-C 4th Generation,,1.23,,,,,1.03 - 1.53,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Triglycerides (GPO),,0.46,,,,,0.44 - 1.99,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,Cholesterol (High Performance),,3.59,R,L,,,3.65 - 6.21,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,LIPID PANEL,LDL Chol Friedewald 4th,,2.15,,,,,0 - 3.34,mmol/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,POSTMENOPAUSAL FEMALE?,<40yrs & amenorrhea >/= 12mo,,Yes,,,,,,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,RETICULOCYTES,Reticulocyte Count %,,1.0,,,,,0.6 - 2.5,%
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,SERUM BETA HCG,"B-hCG, Qualitative",,Negative,,,,,Ref Rng: Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,SERUM BETA HCG,"B-hCG, Quantitative",,<0.6,,,,,Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,TSH,TSH 3rd IS-QT,,1.803,,,,,0.45 - 5.33,mIU/L
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Specific Gravity,,1.024,,,,,1 - 1.04,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur pH,,5.5,,,,,5 - 8,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Protein,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Glucose,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Ketones,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Bilirubin,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Urobilinogen,,Normal,,,,,Ref Rng:Normal,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Blood,,Negative,,,,,Ref Rng:$Negative-Trace,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Nitrite,,Negative,,,,,Ref Rng:Negative,
|
|
CZ100110001,,,31,years,Female,Part 1 Screening,,"Aug 3, 2025 9:05 AM",6225351076,URINE MACRO PANEL,Ur Leukocyte Esterase,,Negative,,,,,Ref Rng:Negative,
|